Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Digestive Diseases and Sciences
|
October 25, 2002
Predictors of pain medication use after percutaneous liver biopsy
Thomas R Riley
Digestive Diseases and Sciences
|
November 25, 2003
Characteristics of upper abdominal pain in those with chronic liver disease
Thomas R Riley, Kenneth Koch
Digestive Diseases and Sciences
|
January 18, 2006
Risk factors and ultrasound can predict chronic hepatitis caused by nonalcoholic fatty liver disease
Thomas R Riley, Amin Kahn
Journal of Clinical Ultrasound : JCU
|
November 11, 2005
Sonographic measurement of the thickness of subcutaneous tissues in nonalcoholic fatty liver disease versus other chronic liver diseases
Thomas R Riley, Michael A Bruno
Digestive Diseases and Sciences
|
February 14, 2008
The effect of processing on liver biopsy core size
Thomas R Riley, Francesca M Ruggiero
Digestive Diseases and Sciences
|
April 3, 2007
Long-term treatment with the combination of amantadine and ribavirin in hepatitis C nonresponders. A case series
Thomas R Riley, Mohammad R Taheri
RMD Open
|
February 18, 2021
Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
Thomas R Riley, Michael D George
Transfusion
|
December 29, 2020
Post-transfusion hemoglobin response in patients with cirrhosis: Can we expect a 1 g/dL rise per unit transfused?
Nicholas Noverati, Elizabeth Federici, Thomas R Riley
World Journal of Gastroenterology
|
June 20, 2014
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease
Nancy Khov, Amol Sharma, Thomas R Riley
Journal of Gastrointestinal and Liver Diseases : JGLD
|
October 2, 2009
Does weight history affect fibrosis in the setting of chronic liver disease?
Thomas R Riley, Mohammad Taheri, Ian R Schreibman
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Digestive Diseases and Sciences
|
October 25, 2002
Predictors of pain medication use after percutaneous liver biopsy
Thomas R Riley
Digestive Diseases and Sciences
|
November 25, 2003
Characteristics of upper abdominal pain in those with chronic liver disease
Thomas R Riley, Kenneth Koch
Digestive Diseases and Sciences
|
January 18, 2006
Risk factors and ultrasound can predict chronic hepatitis caused by nonalcoholic fatty liver disease
Thomas R Riley, Amin Kahn
Journal of Clinical Ultrasound : JCU
|
November 11, 2005
Sonographic measurement of the thickness of subcutaneous tissues in nonalcoholic fatty liver disease versus other chronic liver diseases
Thomas R Riley, Michael A Bruno
Digestive Diseases and Sciences
|
February 14, 2008
The effect of processing on liver biopsy core size
Thomas R Riley, Francesca M Ruggiero
Digestive Diseases and Sciences
|
April 3, 2007
Long-term treatment with the combination of amantadine and ribavirin in hepatitis C nonresponders. A case series
Thomas R Riley, Mohammad R Taheri
RMD Open
|
February 18, 2021
Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
Thomas R Riley, Michael D George
Transfusion
|
December 29, 2020
Post-transfusion hemoglobin response in patients with cirrhosis: Can we expect a 1 g/dL rise per unit transfused?
Nicholas Noverati, Elizabeth Federici, Thomas R Riley
World Journal of Gastroenterology
|
June 20, 2014
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease
Nancy Khov, Amol Sharma, Thomas R Riley
Journal of Gastrointestinal and Liver Diseases : JGLD
|
October 2, 2009
Does weight history affect fibrosis in the setting of chronic liver disease?
Thomas R Riley, Mohammad Taheri, Ian R Schreibman
Page
of 5